References
- Wadasadawala T, Vadgaonkar R, Bajpai J. Management of Isolated Locoregional Recurrences in Breast Cancer: A Review of Local and Systemic Modalities. Clin Breast Cancer. 2017 Nov; 17 (7): 493-502.
- Harms W, Geretschläger A, Cescato C, Buess M, Köberle D, Asadpour B. Current Treatment of Isolated Locoregional Breast Cancer Recurrences. Breast Care 2015; 10: 265–271.
- Elsayed M, Alhussini M, Basha A and Awad A. T. Analysis of loco-regional and distant recurrences in breast cancer after conservative surgery. World Journal of Surgical Oncology (2016) 14:144
- Van Tienhoven G, Voogd AC, Peterse JL, et al.: Prognosis after treatment for locoregional recurrence after mastectomy or breast conserving therapy in two randomized trials (EORTC 10801 and DBCG-82TM). EORTC Breast Cancer Cooperative Group and the Danish Breast Cancer Cooperative Group. Eur J Cancer 1999,35: 32–38.
- Karlsson P, Cole BF, Price KN, Gelber RD, Coates AS, Goldhirsch A. Timing of radiotherapy and chemotherapy after breast-conserving surgery for node-positive breast cancer: long-term results from IBCSG Trials VI and VIIInt J Radiat Oncol Biol Phys. 2016 October 1; 96(2): 273–279
- Liu Y, Zhai X, Li J, Li Z, Ma D and Wang Z. Is there an optimal time to initiate adjuvant chemotherapy to predict benefit of survival in non-small cell lung cancer? Chin J Cancer Res. 2017; 29(3): 263–271
- Chay C, Smith DC. Adjuvant and neoadjuvant therapy in prostate cancer. Semin Oncol. 2001; 28(1): 3-12.
- Dąbrowska A M, Słotwiński R. The immune response to surgery and infection. Centr Eur J Immunol 2014; 39 (4): 532-537
- Gupta AA, Pande N, Kheur S, Raj AT. Assessing the potential role of scafold-mediated local chemotherapy in oral cancer. Oral Oncol. 2018. https://doi.org/10.1016/j.oraloncology.2018.03.009
- Kretlow JD, Mikos AG. From material to tissue: biomaterial development, scafold fabrication, and tissue engineering. AIChE J. 2008; 54(12): 3048-67.
- Langer R. Biomaterials in drug delivery and tissue engineering: one laboratory’s experience. Acc Chem Res. 2000; 33: 94–101.
- Hutmacher DW. Scafolds in tissue engineering bone and cartilage. Biomaterials. 2000; 21: 2529–43.
- Shea LD, Smiley E, Bonadio J, Mooney DJ. DNA delivery frompolymer matrices for tissue engineering. Nat Biotechnol. 1999; 17: 551–4.
- Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev. 2002; 43: 3–12.
- Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials. 2003; 24: 4337–51.
- Lyons F, Partap S, O’Brien FJ. Part 1: scaffolds and surfaces. Technol Health Care. 2008; 16: 305–17.
- Khang G, Lee SJ, Kim MS, Lee HB. Biomaterials: tissue engineering and scaffold. In Webster J (ed.). Encyclopedia of Medical Devices and Instrumentation, Vol 2; 2006: 366–83.
- Chung HJ, Park TG. Surface engineered and drug releasing pre-fabricated scaffolds for tissue engineering. Adv Drug Deliv Rev. 2007;59:249–59.
- Karande ST, Agrawal MC. Functions and requirement of synthetic scaffolds in tissue engineering. In: Laurencin CT, Nair LS (eds.). Nanotechnology and Tissue Engineering: The Scaffolds; 2008:53.
- Ma PX. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev. 2008; 60:184–98.
- Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variablesand applications. Biomaterials. 2003; 24: 4337–51.
- Hoffman AS. Hydrogels for biomedical applications. Adv Drug Deliv Rev. 2002; 43: 3–12.
- Augst AD, Kong HJ, Mooney DJ. Alginate hydrogels as biomaterials. Macromol Biosci. 2006; 6: 623–33.
- Huang S, Fu X. Naturally derived materials-based cell and drug delivery systems in skin regeneration. J Control Release. 2010;142:149–59.
- Park CJ, Clark SG, Lichtensteiger CA, Jamison RD, Johnson AJ. Accelerated wound closure of pressure ulcers in aged mice by chitosan scaffolds with and without bFGF. Acta Biomater. 2009; 5: 1926–36.
- Clark RAF, Singer AJ. Wound repair: basic biology to tissue engineering. London: Academic Press; 2000.
- Bradley M, Cullum N, Nelson EA, Petticrew M, Sheldon T, Torgerson D. Systematic reviews of wound care management: (2). Dressings and topical agents used in the healing of chronic wounds. Health Technol Assess. 1999; 3: 1–35.
- Lee JE, Park JC, Lee HK, Oh SH, Suh H. Laminin modified infection-preventing collagen membrane containing silver sulfadiazine–hyaluronan microparticles. Artif Organs. 2002; 26: 521–8.
- Costa PF. Bone tissue engineering drug delivery. Current Molecular Biology Reports. 2015; 1: 87-93.
- Yao Q, Liu Y, Selvaratnam B, Ranjit T. Koodali D, Sun H. Mesoporous Silicate Nanoparticles/3D Nanofibrous Scaffold-mediated Dual-drug Delivery for Bone Tissue Engineering. doi:10.1016/j.jconrel.2018.04.011
- Agila S. Poornima J. Magnetically Controlled Nano-Composite Based 3D Printed Cell Scaffolds As Targeted Drug Delivery Systems For Cancer Therapy. Proceedings of the 15th IEEE International Conference on Nanotechnology July 27-30, 2015, Rome, Italy.
- Dai J, Jin J, Yang S and Li G. Doxorubicin-loaded PLA/pearl electrospun nanofibrous scaffold for drug delivery and tumor cells treatment. Mater. Res 2017. Express, at press: https://doi.org/10.1088/2053-1591/aa7479
- Bagó J R., Pegna G J., Okolie O, Mohiti-Asli M, Loboa E G, Hingtgen S D. Electrospun nanofibrous scaffolds increase the efficacy of stem cell-mediated therapy of surgically resected glioblastoma DOI: 10.1016/j.biomaterials.2016.03.008
- Bao H, Zhang Q, Xu H, Yan Z. Effects of nanoparticle size on antitumor activity of 10-hydroxycamptothecin-conjugated gold nanoparticles: in vitro and in vivo studies. International Journal of Nanomedicine 2016:11 929–940.
- Chaudhari AA, Vig K, Baganizi DR, Sahu R, Dixit S, Dennis V et al. Future Prospects for Scaffolding Methods and Biomaterials in Skin Tissue Engineering: A Review. Int. J. Mol. Sci. 2016, 17, 1974; doi:10.3390/ijms17121974.
- Grigore ME. Drug Delivery Systems in Hard Tissue Engineering. SF J Biotechnol Biomed Eng. 2018; 1(1): 1001.
- Garg T, Singh O, Arora S & Murthy RSR. Scaffold: A Novel Carrier for Cell and Drug Delivery. Critical Reviews™ in Therapeutic Drug Carrier Systems 2012; 29(1): 1–63.
- Jaisinghani A, Gupta A, Raj AT. The potential use of scaffold-mediated local delivery of bone modulators in accelerated orthodontics: A hypotheses. Medical Hypotheses 2018, doi: https://doi.org/10.1016/j mehy. 2018.07.005.
- Aliperta, R, Welzel PB, Bergmann R, Freudenberg U, Berndt N, Feldmann A et al. Cryogel-supported stem cell factory for customized sustained release of bispecific antibodies for cancer immunotherapy. Sci. Rep. 7, 42855; doi: 10.1038/srep42855(2017).
- Lokteva A, Haberkorna U, Mier W. Multicyclic Peptides as Scaffolds for the Development of Tumor Targeting Agents. Current Medicinal Chemistry, 2016.